WebDoctor Encyclopedia

Article

Mohs Micrographic Surgery

What is Mohs micrographic surgery?

Mohs micrographic surgery (often just called Mohs surgery) is a precise way of removing skin cancer one thin layer at a time. After each layer is removed, the surgeon examines all of its edges under the microscope while the patient waits. If cancer is still present at any edge, the surgeon maps exactly where it is and removes another thin layer only from that spot. The process is repeated until the edges are clear.

The technique is named after Dr Frederic Mohs, an American surgeon who developed it in the 1930s. Modern Mohs surgery uses frozen tissue sections that can be prepared in about an hour, so the whole treatment usually takes place in one day under local anaesthetic.

The main advantages are a very high cure rate and the ability to save as much healthy skin as possible. This is especially valuable on the face, eyelids, nose, lips and ears, where every millimetre of skin matters for appearance and function.

How it differs from standard excision

Feature Standard excision Mohs surgery
Margin A fixed margin of normal-looking skin is cut around the tumour Only as much skin as needed is removed
Margin check A sample of the edges is checked in the laboratory days later Close to 100% of the edge is checked on the same day
Anaesthetic Local or general Almost always local
Timing of repair Often at the same time, before results are known After the edges are confirmed clear
Time in clinic About an hour Several hours
Best suited for Low-risk tumours in less critical areas High-risk tumours or sensitive sites

1. Key facts at a glance

Feature Details
Type of treatment Skin surgery with same-day microscopic margin control
Main uses Basal cell and squamous cell carcinoma, especially on the face; selected rarer skin cancers
Anaesthetic Local anaesthetic injection
Time needed Usually 2-6 hours, sometimes a full day
Number of stages Often 1-2; occasionally more
Repair Stitches, a skin flap, a skin graft or natural healing
Recovery Most people return to normal activities within a few days to two weeks
Main risks Bleeding, infection, scarring, numbness

2. How it works

Skin cancers often have roots that extend beyond what can be seen on the surface. These roots can be irregular and unpredictable, especially in recurrent tumours or aggressive growth patterns. Mohs surgery follows these roots precisely.

Step Purpose
Removing a saucer-shaped layer Takes the visible tumour with a narrow rim of skin
Mapping the tissue The layer is marked with coloured dyes and drawn on a map of the wound
Horizontal sectioning The tissue is flattened and cut so that the entire deep and side edges can be seen on one slide
Same-day microscopy The Mohs surgeon reads the slides while you wait
Targeted re-excision Only areas with remaining cancer are cut again

In standard pathology, the specimen is usually cut like slices of bread, and only a small proportion of the edge is examined. Mohs sectioning looks at almost the entire edge, which is why it misses fewer cancer roots.

3. Who it is for

Expert groups have published appropriate use criteria describing when Mohs surgery is most likely to help. They considered 270 clinical scenarios and judged Mohs to be appropriate in about three-quarters of them, mostly for tumours on the head and neck, recurrent tumours and aggressive subtypes (Ad Hoc Task Force et al., 2012).

Conditions treated

Condition When Mohs is used
Basal cell carcinoma Face and other high-risk sites, recurrent tumours, aggressive growth patterns
Squamous cell carcinoma High-risk tumours, especially on the face, ears and lips
Bowen disease Larger lesions on the face or fingers, or recurrent lesions
Lentigo maligna melanoma Melanoma in situ on the face, often with special stains
Dermatofibrosarcoma protuberans Tumour with long, irregular extensions
Microcystic adnexal carcinoma Deeply infiltrating sweat gland cancer
Sebaceous carcinoma Especially on the eyelid
Extramammary Paget disease Ill-defined edges in the genital or perianal skin
Atypical fibroxanthoma Sun-damaged skin of the head and neck

Features that favour Mohs

Feature Examples
Location Nose, eyelids, lips, ears, around the eyes, fingers, genitals
Size Larger tumours, especially on the face
Growth pattern Infiltrative, morphoeic or micronodular basal cell carcinoma
History Tumours that have come back after previous treatment
Edges Poorly defined borders
Patient factors Weakened immune system, previous radiotherapy to the area

When Mohs is usually not needed

Small, low-risk tumours on the trunk or limbs are usually treated well with standard excision, curettage or other simpler methods. In these situations Mohs adds time and cost without clear benefit.

4. Before the procedure

Step Details
Biopsy The diagnosis is usually confirmed by a biopsy beforehand
Consultation The surgeon checks the site and explains the likely repair
Medicines Blood thinners are usually continued; tell your team about all medicines
Photographs The site may be photographed so it can be found again
Practical planning Arrange transport home, especially for sites near the eyes
On the day Eat a normal breakfast, bring a book, snacks and any regular medicines

5. What to expect: step by step

Step What happens
1. Preparation The area is cleaned and marked
2. Local anaesthetic Injections numb the skin; this stings briefly
3. First layer The visible tumour and a thin rim of tissue are removed
4. Temporary dressing The wound is covered while you wait
5. Laboratory processing The tissue is frozen, cut, stained and placed on slides; this takes around 30-60 minutes
6. Microscope check The surgeon looks for cancer at the edges
7. More layers if needed If cancer remains, more tissue is removed from that exact spot and the cycle repeats
8. Clear margins When no cancer is seen, the removal stage is finished
9. Repair The wound is closed with stitches, a flap or a graft, or left to heal naturally
10. Dressing and advice You receive a pressure dressing and wound care instructions

How long it takes

Most of the day is spent waiting while slides are prepared. Many tumours are cleared after one or two stages. Larger or recurrent tumours can need several stages and a longer day. Occasionally, a complex repair is done on a separate day by a plastic or oculoplastic surgeon.

Types of repair

Repair Description
Natural healing Small wounds in concave areas may heal well on their own
Direct closure Edges are stitched together in a line
Local flap Nearby skin is moved to cover the wound
Skin graft Skin is taken from another site, such as in front of or behind the ear

6. Side effects and risks

Side effect or risk How common Notes
Pain Common, usually mild Simple painkillers are usually enough
Bruising and swelling Common More marked around the eyes; may spread down the face
Bleeding Uncommon Usually controlled with firm pressure for 20 minutes
Infection Uncommon Redness, heat or discharge; treated with antibiotics
Scar Expected Usually fades over 6-12 months
Numbness Common Small skin nerves are cut; feeling often returns over months
Flap or graft problems Uncommon Part of the flap or graft may not take
Nerve weakness Rare If a motor nerve near the surface is affected
Recurrence Low Further treatment may be needed

7. Results and outlook

Mohs surgery has some of the lowest recurrence rates of any skin cancer treatment.

Evidence Main finding
Meta-analysis of 17 studies Recurrence about 3.1% after micrographic surgery versus 5.3% after conventional excision; the benefit was clearest for basal cell carcinoma and primary tumours (Lacerda et al., 2024)
Review of basal cell carcinoma data Mohs is viewed as the gold standard for high-risk basal cell carcinoma, though randomised evidence is limited (Brown et al., 2022)
Melanoma review For melanoma in situ and selected invasive melanomas, local recurrence and survival were similar to or better than wide local excision (Shah et al., 2024)

The review of basal cell carcinoma noted some evidence that Mohs leaves a smaller wound, although direct proof of a better cosmetic result is lacking, and cost comparisons vary between healthcare systems (Brown et al., 2022).

8. Recovery and aftercare

Recovery timeline

Period What to expect
First 24-48 hours Keep the pressure dressing on and dry; rest and avoid bending
Days 2-7 Gentle cleaning and new dressings as instructed; swelling peaks then eases
Days 7-14 Stitches removed if they are not dissolvable
Weeks 2-6 Wound heals; avoid heavy exercise early on if advised
Months 3-12 Scar softens and fades

Wound care tips

  • Keep the head raised on pillows for the first nights after facial surgery
  • Avoid alcohol and strenuous exercise for a few days to reduce bleeding
  • Use petroleum jelly on the wound if advised, to keep it moist
  • Do not smoke, as it slows healing and can cause flaps or grafts to fail
  • Contact your team for bleeding that does not stop with pressure, or signs of infection

Long-term follow-up

People who have had one skin cancer have a higher chance of developing another. Regular skin checks, daily sun protection and prompt reporting of new or changing spots are important.

Check Typical timing
Skin examination Every 6-12 months, depending on risk
Self-checks Monthly
Sun protection Daily, all year round

Living with the scar

Facial scars can feel very noticeable in the first weeks, when they are red and raised. Most settle and become paler and flatter over the following year. Gentle massage once the wound has healed, sun protection over the scar, and patience usually help. If a scar remains thick or pulls on nearby features, treatments such as steroid injections, laser or a small revision procedure can be discussed.

9. Alternatives

Alternative Best suited for
Standard surgical excision Most low-risk basal and squamous cell carcinomas
Curettage and cautery Small, superficial, low-risk tumours
Cryotherapy Small superficial lesions
Topical treatments (imiquimod, 5-fluorouracil) Superficial basal cell carcinoma and Bowen disease
Photodynamic therapy Superficial basal cell carcinoma and Bowen disease
Radiotherapy People unable to have surgery, or difficult sites
Hedgehog pathway inhibitors or immunotherapy Advanced or inoperable tumours

10. Frequently asked questions

Question Answer
Will I be awake? Yes; local anaesthetic numbs the area and you can talk and rest between stages
How big will the wound be? Often bigger than the visible spot, because roots are removed too
Can I drive home? Not if the surgery is near your eyes or a large dressing blocks your vision
Is it painful? The injections sting; afterwards most people need only simple painkillers
Will I need a second operation? Usually not, unless a complex repair is planned separately
Can the cancer come back? It is uncommon, but regular skin checks are still important
Is Mohs used for melanoma? For some melanomas in situ and early melanomas, particularly on the face

11. Questions to ask your care team

  • Why is Mohs surgery recommended for my skin cancer?
  • How many stages do you expect?
  • What kind of repair will I need, and what will the scar look like?
  • Should I stop any medicines before the day?
  • Will I be able to drive or work the next day?
  • How should I care for the wound?
  • How often should I have skin checks?

Resources

  1. Ad Hoc Task Force et al. (2012) ‘AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery’, Journal of the American Academy of Dermatology, 67(4), pp. 531-550.
  2. Brown, A.C. et al. (2022) ‘A review of the evidence for Mohs micrographic surgery. Part 2: basal cell carcinoma’, Clinical and Experimental Dermatology, 47(10), pp. 1794-1804.
  3. Lacerda, P.N. et al. (2024) ‘Efficacy of micrographic surgery versus conventional excision in reducing recurrence for basal cell carcinoma and squamous cell carcinoma: a systematic review and meta-analysis’, Journal of the European Academy of Dermatology and Venereology, 38(6), pp. 1058-1069.
  4. Shah, P. et al. (2024) ‘Mohs micrographic surgery in the surgical treatment paradigm of melanoma in situ and invasive melanoma: a clinical review of treatment efficacy and ongoing controversies’, Journal of the American Academy of Dermatology, 91(3), pp. 499-507.
  5. National Cancer Institute (2026) Skin Cancer Treatment (PDQ) – Health Professional Version. Available at: https://www.cancer.gov/types/skin/hp/skin-treatment-pdq (Accessed: October 2026).

Prepared by the editorial team, October 2026.